ARIAD to Present at the 30th Annual J.P. Morgan Healthcare Conference07:35 EST Wednesday, January 04, 2012 CAMBRIDGE, Mass. (Business Wire) -- ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will webcast its presentation at the 30th Annual J.P. Morgan Healthcare Conference in San Francisco. Harvey J. Berger, M.D., chairman and chief executive officer, will provide an overview of the Company's business on Tuesday, January 10, 2012 at 10:00 a.m. (PT). The ARIAD presentation at the J.P. Morgan Healthcare Conference will be webcast live and can be accessed by visiting the investor relations section of the Company's website at http://www.ariad.com/investor. A replay of the webcast presentation will also be available and archived on the site for three weeks. About ARIAD ARIAD Pharmaceuticals, Inc. is an emerging global oncology company focused on the discovery, development and commercialization of medicines to transform the lives of cancer patients. ARIAD's approach to structure-based drug design has led to three internally discovered, molecularly targeted product candidates for drug-resistant and difficult-to-treat cancers, including certain forms of chronic myeloid leukemia, soft tissue and bone sarcomas and non-small cell lung cancer. For additional information, visit http://www.ariad.com. ARIAD Pharmaceuticals, Inc.For InvestorsMaria E. Cantor, 617-621-2208Maria.cantor@ariad.comorFor MediaLiza Heapes, 617-621-2315Liza.heapes@ariad.com